Prevalence and associated factors for HIV-1 transmitted drug resistance in voluntary clients for counseling and testing in Southern Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 49, Issue 4, 2016, Pages 487-493

  Weng, Ya Wei ^a   Tsai, Hung Chin ^a,b   Lee, Susan Shin Jung ^a,b   Wu, Kuan Sheng ^a   Sy, Cheng Len ^a   Chen, Jui Kuang ^a   Chen, Yao Shen ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Drug resistance; HIV; Sexually transmitted diseases

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANAL INTERCOURSE; ANTIVIRAL RESISTANCE; ARTICLE; CD4 LYMPHOCYTE COUNT; CONDOM USE; DEMOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; NONHUMAN; PATIENT COUNSELING; PHYLOGENETIC TREE; PHYLOGENY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; TAIWAN; VIRUS LOAD; VIRUS TRANSMISSION; ADULT; DRUG EFFECTS; GENETICS; HIV INFECTIONS; QUESTIONNAIRE; RISK FACTOR; SEXUALLY TRANSMITTED DISEASES, VIRAL; STATISTICAL MODEL; VIROLOGY; YOUNG ADULT;

ADULT; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; MALE; PHYLOGENY; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, VIRAL; SURVEYS AND QUESTIONNAIRES; TAIWAN; YOUNG ADULT;

EID: 84992731133     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2014.08.002     Document Type: Article

References (29)

1. 1 Palella, F.J. Jr., Armon, C., Buchacz, K., Cole, S.R., Chmiel, J.S., Novak, R.M., et al. The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Ann Intern Med 151 (2009), 73–84.
2. 2 Kuritzkes, D.R., Lalama, C.M., Ribaudo, H.J., Marcial, M., Meyer, W.A. 3rd, Shikuma, C., et al. Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1–infected subjects. J Infect Dis 197 (2008), 867–870.
3. 3 World Health Organization, WHO HIV drug resistance report. Geneva, Switzerland, 2012.
4. 4 van Griensven, F., de Lind van Wijngaarden, J.W., Baral, S., Grulich, A., The global epidemic of HIV infection among men who have sex with men. Curr Opin HIV AIDS 4 (2009), 300–307.
5. 5 Liao, L., Xing, H., Shang, H., Li, J., Zhong, P., Kang, L., et al. The prevalence of transmitted antiretroviral drug resistance in treatment-naïve HIV-infected individuals in China. J Acquir Immune Defic Syndr 53 (2010), S10–S14.
6. 6 Hattori, J., Shiino, T., Gatanaga, H., Yoshida, S., Watanabe, D., Minami, R., et al. Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan. Antiviral Res 88 (2010), 72–79.
7. 7 Kim, M.H., Song, J.E., Ahn, J.Y., Kim, Y.C., Oh, D.H., Choi, H., et al. HIV antiretroviral resistance mutations among antiretroviral treatment-naïve and -experienced patients in South Korea. AIDS Res Hum Retroviruses 29 (2013), 1617–1620.
8. 8 Sungkanuparph, S., Sukasem, C., Kiertiburanakul, S., Pasomsub, E., Chantratita, W., Emergence of HIV-1 drug resistance mutations among antiretroviral-naïve HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand. J Int AIDS Soc, 15, 2012, 12.
9. 9 Lai, C.C., Hung, C.C., Chen, M.Y., Sun, H.Y., Lu, C.L., Tseng, Y.T., et al. Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line antiretroviral therapy in Taiwan. J Antimicrob Chemother 67 (2012), 1254–1260.
10. 10 Gandhi, R.T., Wurcel, A., Rosenberg, E.S., Johnston, M.N., Hellmann, N., Bates, M., et al. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. Clin Infect Dis 37 (2003), 1693–1698.
11. 11 Chang, S.Y., Chen, M.Y., Lee, C.N., Sun, H.Y., Ko, W., Chang, S.F., et al. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. J Antimicrob Chemother 61 (2008), 689–693.
12. 12 Lee, K.H., Ho, T.S., Shen, C.F., Wang, S.M., Ko, W.C., Liu, C.C., Clinical and laboratory characteristics of human immunodeficiency virus-infected adolescents: experience from a single medical center. J Microbiol Immunol Infect 45 (2012), 329–336.
13. 13 Baral, S., Sifakis, F., Cleghorn, F., Breyer, C., Elevated risk for HIV infection among men who have sex with men in low-and middle-income countries 2000–2006: a systemic review. PLoS Med, 12, 2007, e339.
14. 14 Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012 Report on the global AIDS epidemic. Geneva, Switzerland, 2012.
15. 15 Koblin, B.A., Husnik, M.J., Colfax, G., Huang, Y., Madison, M., Mayer, K., et al. Risk factors for HIV infection among men who have sex with men. AIDS 20 (2006), 731–739.
16. 16 Levy, I., Mor, Z., Anis, E., Maayan, S., Leshem, E., Pollack, S., et al. Men who have sex with men, risk behavior, and HIV infection: integrative analysis of clinical, epidemiological, and laboratory databases. Clin Infect Dis 52 (2011), 1363–1370.
17. 17 Greenblatt, R.M., Lukehart, S.A., Plummer, F.A., Quinn, T.C., Critchlow, C.W., Ashley, R.L., et al. Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 2 (1988), 47–50.
18. 18 Palacios, R., Jiménez-Oñate, F., Aguilar, M., Galindo, M.J., Rivas, P., Ocampo, A., et al. Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients. J Acquir Immune Defic Syndr 44 (2007), 356–359.
19. 19 Johnson, L.F., Lewis, D.A., The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis 35 (2008), 946–959.
20. 20 Wu, H., Wu, P.Y., Li, S.Y., Chang, S.Y., Liu, W.C., Wu, C.H., et al. Maximising the potential of voluntary counselling and testing for HIV: sexually transmitted infections and HIV epidemiology in a population testing for HIV and its implications for practice. Sex Transm Infect 88 (2012), 612–616.
21. 21 Jain, V., Sucupira, M.C., Bacchetti, P., Hartogensis, W., Diaz, R.S., Kallas, E.G., et al. Differential persistence of transmitted HIV-1 drug resistance mutation classes. J Infect Dis 203 (2011), 1174–1181.
22. 22 Little, S.J., Frost, S.D., Wong, J.K., Smith, D.M., Pond, S.L., Ignacio, C.C., et al. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol 82 (2008), 5510–5518.
23. 23 Castro, H., Pillay, D., Cane, P., Asboe, D., Cambiano, V., Phillips, A., et al. Persistence of HIV-1 transmitted drug resistance mutations. J Infect Dis 208 (2013), 1459–1463.
24. 24 Sungkanuparph, S., Oyomopito, R., Sirivichayakul, S., Sirisanthana, T., Li, P.C., Kantipong, P., et al. HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia studies to evaluate resistance-monitoring study. Clin Infect Dis 52 (2011), 1053–1057.
25. 25 Llibre, J.M., Santos, J.R., Puig, T., Moltó, J., Ruiz, L., Paredes, R., et al. Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz. J Antimicrob Chemother 62 (2008), 909–913.
26. 26 Manosuthi, W., Thongyen, S., Nilkamhang, S., Manosuthi, S., Sungkanuparph, S., HIV-1 drug resistance-associated mutations among antiretroviral-naive Thai patients with chronic HIV-1 infection. J Med Virol 85 (2013), 194–199.
27. 27 Mackie, N.E., Dunn, D.T., Dolling, D., Garvey, L., Harrison, L., Fearnhill, E., et al. The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults. AIDS 27 (2013), 2245–2253.
28. 28 Smith, D.M., May, S.J., Tweeten, S., Drumright, L., Pacold, M.E., Kosakovsky Pond, S.L., et al. A public health model for the molecular surveillance of HIV transmission in San Diego, California. AIDS 23 (2009), 225–232.
29. 29 Drescher, S.M., von Wyl, V., Yang, W.L., Böni, J., Yerly, S., Shah, C., et al. Treatment-naive individuals are the major source of transmitted HIV-1 drug-resistance in MSMs in the Swiss HIV cohort study. Clin Infect Dis 58 (2014), 285–294.